Abe K - Search Results

1

The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension.

Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF. Bogaard HJ, et al. Among authors: abe k. Chest. 2009 Mar;135(3):794-804. doi: 10.1378/chest.08-0492. Chest. 2009. PMID: 19265089 Review.

2

Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.

Abe K, Tawara S, Oi K, Hizume T, Uwatoku T, Fukumoto Y, Kaibuchi K, Shimokawa H. Abe K, et al. J Cardiovasc Pharmacol. 2006 Dec;48(6):280-5. doi: 10.1097/01.fjc.0000248244.64430.4a. J Cardiovasc Pharmacol. 2006. PMID: 17204906

3

Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.

Abe K, Toba M, Alzoubi A, Ito M, Fagan KA, Cool CD, Voelkel NF, McMurtry IF, Oka M. Abe K, et al. Circulation. 2010 Jun 29;121(25):2747-54. doi: 10.1161/CIRCULATIONAHA.109.927681. Epub 2010 Jun 14. Circulation. 2010. PMID: 20547927

4

Inhibition of TLR9-NF-κB-mediated sterile inflammation improves pressure overload-induced right ventricular dysfunction in rats.

Yoshida K, Abe K, Ishikawa M, Saku K, Shinoda-Sakamoto M, Ishikawa T, Watanabe T, Oka M, Sunagawa K, Tsutsui H. Yoshida K, et al. Among authors: abe k. Cardiovasc Res. 2019 Mar 1;115(3):658-668. doi: 10.1093/cvr/cvy209. Cardiovasc Res. 2019. PMID: 30239623

5

Proteinase-activated receptor 1 antagonism ameliorates experimental pulmonary hypertension.

Kuwabara Y, Tanaka-Ishikawa M, Abe K, Hirano M, Hirooka Y, Tsutsui H, Sunagawa K, Hirano K. Kuwabara Y, et al. Among authors: abe k. Cardiovasc Res. 2019 Jul 1;115(8):1357-1368. doi: 10.1093/cvr/cvy284. Cardiovasc Res. 2019. PMID: 30423156

6

Balloon pulmonary angioplasty improves right atrial reservoir and conduit functions in chronic thromboembolic pulmonary hypertension.

Yamasaki Y, Abe K, Kamitani T, Hosokawa K, Kawakubo M, Sagiyama K, Hida T, Matsuura Y, Murayama Y, Funatsu R, Tsutsui H, Yabuuchi H. Yamasaki Y, et al. Among authors: abe k. Eur Heart J Cardiovasc Imaging. 2020 Aug 1;21(8):855-862. doi: 10.1093/ehjci/jeaa064. Eur Heart J Cardiovasc Imaging. 2020. PMID: 32359071

7

Eicosapentaenoic acid ameliorates pulmonary hypertension via inhibition of tyrosine kinase Fyn.

Kurahara LH, Hiraishi K, Yamamura A, Zhang Y, Abe K, Yahiro E, Aoki M, Koga K, Yokomise H, Go T, Ishikawa K, Bo Z, Kishi H, Kobayashi S, Aoki-Shoi N, Toru S, Inoue R, Hirano K. Kurahara LH, et al. Among authors: abe k. J Mol Cell Cardiol. 2020 Nov;148:50-62. doi: 10.1016/j.yjmcc.2020.08.013. Epub 2020 Sep 2. J Mol Cell Cardiol. 2020. PMID: 32889002 Free article.

8

Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats.

Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, Takeshit A. Abe K, et al. Circ Res. 2004 Feb 20;94(3):385-93. doi: 10.1161/01.RES.0000111804.34509.94. Epub 2003 Dec 11. Circ Res. 2004. PMID: 14670839

9

Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.

Jiang BH, Tawara S, Abe K, Takaki A, Fukumoto Y, Shimokawa H. Jiang BH, et al. Among authors: abe k. J Cardiovasc Pharmacol. 2007 Feb;49(2):85-9. doi: 10.1097/FJC.0b013e31802df112. J Cardiovasc Pharmacol. 2007. PMID: 17312448

10

Noninvasive and accurate evaluation of cardiac output in patients with pulmonary hypertension.

Abe K. Abe K. Circ J. 2013;77(9):2251-2. doi: 10.1253/circj.cj-13-0893. Epub 2013 Jul 31. Circ J. 2013. PMID: 23903018 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,008 results

Search Page

Filters